Drug Company Gives $10-Million to Cancer Society
February 14, 2007
AstraZeneca, an international pharmaceutical company based in London, pledged $10-million to the American Cancer Society, in Atlanta, reports the Associated Press.
The donation will support the charity’s efforts to provide cancer patients with transportation, financial and emotional assistance, and other aid. The donation is the second-largest in the Cancer Society’s history, officials said.
(Free registration is required to view the article on the New York Times site.)
